SomatoPulse (Tesa 10mg/Ipamorelin 3mg)

SomatoPulse combines 10mg Tesamorelin with 3mg Ipamorelin in a single lyophilized vial to allow investigation of complementary growth hormone signaling pathways. By pairing Tesamorelin, Growth Hormone–Releasing Hormone (GHRH) analog, with Ipamorelin, a selective ghrelin receptor agonist, SomatoPulse is designed to support dual-receptor stimulation of endogenous growth hormone release within controlled laboratory models. Tesamorelin (10mg)  – a synthetic analog of Growth Hormone–Releasing Hormone (GHRH). It is designed to stimulate the anterior pituitary gland to produce and release endogenous growth hormone (GH) in a physiologic, pulsatile manner. Ipamorelin (3mg) – a selective growth hormone secretagogue (GHS) studied for its ability to stimulate endogenous growth hormone (GH) release by activating the ghrelin (GHSR-1a) receptor in the pituitary. For research use only. Refer to the Certificate of Analysis for exact vial specifications. Batch SOM130326 analysis